Skaff Michael C bought VVOS
June 30, 2026 · Form 4 insider transaction
Skaff Michael C bought 1,890,164 shares of Vivos Therapeutics, Inc. at $0.58 per share, a transaction worth $1.10M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 15 days after the transaction.
Footnotes
On June 30, 2026, V-Co Investors 4 LLC converted a bridge promissory note in the amount of $1,000,000 entered into between the reporting person and the Issuer into shares of the Issuer's Series A Convertible Preferred Stock, based on $0.456 per share plus $0.125 per share in accordance with the Nasdaq minimum price rules.; The convertible preferred stock is convertible at any time, at the holder's election, subject to a beneficial ownership limitation, and has no expiration date.; Michael C. Skaff serves as Managing Director of SP Manager LLC, the Manager of V-Co Investors 4 LLC. Michael C. Skaff and SP Manager LLC disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.